FR3079140B1 - Composition prebiotique - Google Patents

Composition prebiotique Download PDF

Info

Publication number
FR3079140B1
FR3079140B1 FR1852534A FR1852534A FR3079140B1 FR 3079140 B1 FR3079140 B1 FR 3079140B1 FR 1852534 A FR1852534 A FR 1852534A FR 1852534 A FR1852534 A FR 1852534A FR 3079140 B1 FR3079140 B1 FR 3079140B1
Authority
FR
France
Prior art keywords
prebiotic composition
prebiotic
relates
composition
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1852534A
Other languages
English (en)
Other versions
FR3079140A1 (fr
Inventor
Christine Chirat
Bertrand Toussaint
Vivien Deloule
Jadwiga Chroboczek
Claire Boisset-Helbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Polytechnique de Grenoble
Universite Grenoble Alpes
Centre Hospitalier Universitaire Grenoble Alpes
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Polytechnique de Grenoble
Universite Grenoble Alpes
Centre Hospitalier Universitaire Grenoble Alpes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Polytechnique de Grenoble, Universite Grenoble Alpes, Centre Hospitalier Universitaire Grenoble Alpes filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1852534A priority Critical patent/FR3079140B1/fr
Priority to US16/981,355 priority patent/US20210069236A1/en
Priority to EP19718443.5A priority patent/EP3768279A1/fr
Priority to CN201980021144.6A priority patent/CN112218643A/zh
Priority to JP2020550735A priority patent/JP2021518402A/ja
Priority to PCT/FR2019/050671 priority patent/WO2019180396A1/fr
Publication of FR3079140A1 publication Critical patent/FR3079140A1/fr
Application granted granted Critical
Publication of FR3079140B1 publication Critical patent/FR3079140B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Le domaine de l'invention est celui des compositions prébiotiques. En particulier, l'invention concerne une composition prébiotique comprenant des galactoglucomannanes, ainsi que son procédé de production. L'invention vise également l'utilisation de cette composition prébiotique pour augmenter la production d'acide gras à chaines courtes chez les bactéries du microbiote intestinal.
FR1852534A 2018-03-23 2018-03-23 Composition prebiotique Active FR3079140B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1852534A FR3079140B1 (fr) 2018-03-23 2018-03-23 Composition prebiotique
US16/981,355 US20210069236A1 (en) 2018-03-23 2019-03-25 Prebiotic composition
EP19718443.5A EP3768279A1 (fr) 2018-03-23 2019-03-25 Composition prebiotique comprenant des galactoglucomannanes
CN201980021144.6A CN112218643A (zh) 2018-03-23 2019-03-25 包含半乳葡甘露聚糖的益生元组合物
JP2020550735A JP2021518402A (ja) 2018-03-23 2019-03-25 ガラクトグルコマンナンを含むプレバイオティック組成物
PCT/FR2019/050671 WO2019180396A1 (fr) 2018-03-23 2019-03-25 Composition prebiotique comprenant des galactoglucomannanes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1852534 2018-03-23
FR1852534A FR3079140B1 (fr) 2018-03-23 2018-03-23 Composition prebiotique

Publications (2)

Publication Number Publication Date
FR3079140A1 FR3079140A1 (fr) 2019-09-27
FR3079140B1 true FR3079140B1 (fr) 2020-10-02

Family

ID=62948207

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1852534A Active FR3079140B1 (fr) 2018-03-23 2018-03-23 Composition prebiotique

Country Status (6)

Country Link
US (1) US20210069236A1 (fr)
EP (1) EP3768279A1 (fr)
JP (1) JP2021518402A (fr)
CN (1) CN112218643A (fr)
FR (1) FR3079140B1 (fr)
WO (1) WO2019180396A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113575955A (zh) * 2021-07-02 2021-11-02 青岛凯特生物科技有限公司 一种益生元组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152089A2 (fr) * 2008-06-09 2009-12-17 Temple-Inland Composition prébiotique et procédés pour la préparer et l'utiliser
FI126211B (en) * 2012-11-09 2016-08-15 Montisera Ltd Wood-derived hemicelluloses for use in the treatment of lower urinary tract symptoms and disorders
CN104870467A (zh) * 2012-12-07 2015-08-26 丹尼斯科美国公司 β-甘露聚糖酶的组合物及使用方法
FI127740B (en) * 2015-05-29 2019-01-15 Upm Kymmene Corp Method and apparatus for forming a lignin fraction and lignin composition and use thereof

Also Published As

Publication number Publication date
WO2019180396A1 (fr) 2019-09-26
CN112218643A (zh) 2021-01-12
JP2021518402A (ja) 2021-08-02
FR3079140A1 (fr) 2019-09-27
EP3768279A1 (fr) 2021-01-27
US20210069236A1 (en) 2021-03-11

Similar Documents

Publication Publication Date Title
MA35195B1 (fr) Compositions lipidiques algales, leurs procédés de préparation et leurs utilisations
MA41185B1 (fr) Composés d'acide isoxazole hydroxamique comme inhibiteurs de lpxc
MA34909B1 (fr) Triterpénoïdes modifi2s en c-17 et c-3 presentant une activité inhibitrice de la maturation du vih
MA34169B1 (fr) Dérivés d'acide 1-amino-2-cyclopropyléthylboronique
MA41778A (fr) Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine
PH12017501473A1 (en) Novel proteins specific for pyoverdine and pyochelin
BR112018013104B8 (pt) Composição e método para crescimento de cabelos ou pelos
BRPI0920698A8 (pt) Método para produção de uma composição líquida não-gel, neutra, estável ao armazenamento e enteral
EA201000400A1 (ru) Твердые жировые композиции, содержащие полиненасыщенные жирные кислоты, и способы их получения и использования
EA201400537A1 (ru) 18-МЕТИЛ-6,7-МЕТИЛЕН-3-ОКСО-17-ПРЕГН-4-ЕН-21,17β-КАРБОЛАКТОНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ ЭНДОМЕТРИОЗА
MA37439A1 (fr) Inhibiteurs de dgat1 à ponts éthers cycliques pour le traitement de troubles medies par l'acyle coa-diacylglycerol transferase 1 (dgat1).
MA38567A1 (fr) Variantes de pertuzumab et leur évaluation
EA201991467A1 (ru) Состав смеси, содержащий силикат и микробные и/или растительные клетки и полиненасыщенную жирную кислоту, имеющую по меньшей мере 20 атомов углерода (lc-pufa)
FR3068979B1 (fr) Composition d'adhesif (meth)acrylique, son procede de preparation et son utilisation
PH12020551796A1 (en) Branched fatty acids and esters thereof
EA201990560A1 (ru) Композиции, содержащие тритерпеноиды, и их применение для лечения оптической нейропатии
DE602005020185D1 (de) Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4henprodukte für dieses verfahren
MA38646B1 (fr) Formulation a liberation modifiee pour traiter, par ex. La maladie de parkinson et la dyskinesie induite par l-dopa.
AU2013408771A8 (en) Prebiotic oral care compositions containing an alkyl glycoside
BRPI0924194A8 (pt) Composições alimentícias em pedaços de geleia
BR112018001164A2 (pt) composto de fórmula geral, composição farmacêutica e método para o tratamento de uma doença cardiovascular
FR3079140B1 (fr) Composition prebiotique
BR112015013689A2 (pt) composições fluidas de cuidado oral contendo peróxido
MA43960B1 (fr) Triterpénoïdes modifiés en c-3 et c-17 utilisés comme inhibiteurs du vih-1
FR3064638B1 (fr) Nouveau gelifiant polyurethane

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20190927

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

CL Concession to grant licences

Name of requester: SATT LINKSIUM GRENOBLE ALPES, FR

Effective date: 20210316

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7